| -- Primary Expertise -- |
-- Description -- |
|
|
Dr. William R. Jarvis was an author
on the Centers for Disease Control and Prevention (CDC) Guideline for
Prevention of Transmission of M.
tuberculosis in Healthcare Settings
and the WHO Guideline for Prevention of M. tuberculosis Transmission in
Healthcare Settings in Developing Countries. He was also involved in
the conduct of studies of the efficacy of infection control measures in
preventing hospital transmission of M. tuberculosis and of BCG vaccine
in the prevention of TB and/or mycobacteremia in patients and/or
healthcare workers in the United States, Thailand, Taiwan, Malawi, and
other countries. In addition, he participated in a number of studies
assessing the immunology of BCG vaccine and its ability to prevent
TB. Recently, he was a member of the CDC Division of TB
Elimination's TBSC Working Group.
|
|
|
For 17 years, Dr. Jarvis
coordinated and supervised the branch at the Centers for Disease
Control and Prevention (CDC) that was responsible for conducting
investigations of outbreaks in healthcare settings. He and his team
investigated over 150 outbreaks, solved them all, and prevented
recurrences. The investigations led to over 200 peer-reviewed
publications. Many of these outbreaks involved intrinsic (at the time
of manufacture) or extrinsic (at time of use) contamination with
bacteria. In each outbreak, the source and mode of contamination was
identified. Often, these investigations involved collaboration with
manufacturers, the Food and Drug Administration, and local and state
health departments. Dr. Jarvis is a world's expert on outbreak
investigations in health care settings and frequently makes
presentations on this subject. |
|
|
Dr. Jarvis is board certified in
pediatrics and has training in pediatric infectious diseases,
epidemiology, and public health and preventive medicine. He has
attended in pediatric infectious diseases at Emory University for over
20 years. In addition, he frequently gives lectures, teaches courses,
or mentors medical students, public health students or pediatric
infectious disease fellows. He has written many peer review
publications, book chapters, and surveillance reports on clinical
medicine, particularly involving infectious diseases and
healthcare-associated infections. Dr. Jarvis often lectures on clinical
infectious diseases at national and international meetings. In
addition, he has trained over 50 U.S. and over 20 international
clinicians in healthcare epidemiology and infection prevention and
control. |
|
|
Dr. Jarvis has been involved in
conducting clinical research for over 23 years. He has developed or
supervised the development and conduct of nearly 100 study protocols,
is familiar with ethical and human subjects issues, study design, data
collection, data analysis and publication of data from studies. He has
over 70 publications of clinical studies, most involving healthcare
epidemiology, prevention and control of infections in hospitals,
prevention of M. tuberculosis transmission in healthcare settings, and
in enhancing clinical medicine and microbiology in developing
countries. In addition, he has designed and conducted studies of
detection of bloodstream infections in febrile patients in developing
countries. |
|
|
Dr. Jarvis was trained in
epidemiology and public health at Yale University School of Medicine
and in Preventive Medicine at the Centers for Disease Control and
Prevention (CDC). He was an adjunct assistant professor at the Rollins
School of Public Health at Emory University where he lectured on
prevention and control of healthcare-associated infections for over 10
years. He held a number of positions at CDC, including Assistant Chief
of the National Nosocomial Infections Surveillance (NNIS) system, and
Chief of the Epidemiology Branch. For 17 years, he coordinated and
supervised the Branch at the Centers for Disease Control and Prevention
(CDC) that was responsible for conducting investigations of outbreaks
in healthcare settings. He and his team investigated over 150
outbreaks, solved them all, and prevented recurrences. The
investigations led to over 200 peer-reviewed publications. Many of
these outbreaks involved intrinsic (at the time of manufacture) or
extrinsic (at time of use) contamination with bacteria. In each
outbreak, the source and mode of contamination was identified. Often,
these investigations involved collaboration with manufacturers, the
Food and Drug Administration and local and state health departments. He
also was responsible for the development and publication of many of the
Hospital Infection Program (now the Division of Healthcare Quality
Promotion)/CDC Guidelines for the Prevention of Nosocomial
Infections. Dr. Jarvis currently is Chair of the FDA's General
Hospital and Personal Use Devices Committee.
|
|
|
For 17 years, Dr. Jarvis
coordinated and supervised the Branch at the Centers for Disease
Control and Prevention (CDC) that was responsible for conducting
investigations of outbreaks in healthcare settings. He and his team
investigated over 150 outbreaks, solved them all, and prevented
recurrences. The investigations led to over 200 peer-reviewed
publications. His branch was the first to investigate outbreaks
associated with provision of intravenous therapy in home settings.
These led to a JAMA article on bloodstream infections in home care
associated with needleless devices. In addition, he and his team
investigated a number of other outbreaks in home health care settings
and published these results. He has published on the importance of
surveillance for infections associated with home health care. He has
been a speaker on infections and infection prevention in home care at
national and international meetings. He has worked with national
organizations and local and state health departments to develop
definitions of and methods for surveillance for infections in home care. |
|
|
Dr. Jarvis is a board certified
pediatrician with subsequent training in pediatric infectious diseases.
He has been a reviewer and author of many of the chapters in the
American Academy of Pediatrics (AAP) Red Book, a guide for clinicians
on immunization practices. In addition, he has conducted and published
several studies on immunization practices in patients and healthcare
workers. He was the supervisor of the Hospital Infections Program,
Centers for Disease Control and Prevention's Guideline for Prevention
of Infection In Healthcare Workers. He has been a vocal advocate for
immunization of pediatric patients and for healthcare workers to
prevent the emergence of antimicrobial resistance. He is an author of
the 12 steps program for prevention of antimicrobial resistance in
pediatric patients, which highlights the importance of immunization. |
|
|
Dr. Jarvis was a co-author of the
CDC
Hand Hygiene Guideline and has been involved in numerous studies
evaluating the impact of antimicrobial soaps. In addition, he has
conducted numerous outbreak investigations in which hand hygiene was a
factor. He has consulted with several manufacturers who produce hand
hygiene (antibacterial soaps) products. He has been active in
recommending simple and effective measures to enhance hand hygiene in
international healthcare settings. |
|
|
Dr. Jarvis has been a leader in
infection control for over 20 years. He has been President of The
Society for Healthcare Epidemiologists of America (SHEA), Member and
Chair of the Association for
Professionals in Infection Control, Inc. (APIC) Research Foundation,
and is active in other SHEA and APIC activities. He has investigated
and published over 150 hospital outbreaks, supervised and was an author
on many of the current infection control guidelines, conducted hundreds
of epidemiologic studies, and trained over 50 EIS officers at CDC. He
spent over 22 years at CDC in leadership positions in infection control
and is considered one of the world's experts in this area. He is the
former Editor of the infection control journal, Infection Control and
Hospital Epidemiology. Dr. Jarvis currently is Chair of
the FDA's General Hospital and Personal Use Devices Committee. He
has edited three books on healthcare epidemiology, including the book,
Hospital Infections.
|
|
|
Dr. Jarvis has published a wide
variety of infection prevention guidelines at CDC and with SHEA. He has
conducted numerous intervention studies documenting prevention in
action. He has over 350 publications on infection prevention. He is
viewed as one of the world's experts in real infection prevention in
the United States and throughout the world. He is working with a
variety of medical manufacturers to implement infection prevention
measures throughout the world. Dr. Jarvis has conducted studies to
document the prevention and control of a wide variety of outbreaks and
of methicillin-resistant Staphylococcus
aureus (MRSA), M. tuberculosis,
vancomycin-resistant enterococcus (VRE), and other
antimicrobial-resistant pathogens. |
|
|
Dr. Jarvis is trained in pediatric
infectious diseases and has practiced for over 25 years. He was on the
faculty at Emory University School of Medicine and has written widely
on the subject. He has trained numerous infectious diseases fellows. He
speaks widely on infectious disease treatment and prevention. He has
over 600 infectious disease publications. |
|
|
Dr. Jarvis has been involved and a
leader in infectious disease control for over 25 years. He has written
widely, made presentations, and consulted on infectious disease control
throughout the United States and the world. He has over 350
publications in the area and consults with medical device and product
manufacturers on
this subject. |
|
|
Dr. Jarvis has wide experience with
medical devices. While at CDC, he often supervised outbreak
investigations involving such devices. He has worked with the FDA and
State Health Departments on medical device evaluation. He has consulted
with medical device manufacturers. He has been on national and
international committees making recommendations on medical device use.
He helped design the CDC's National Nosocomial Infections Surveillance
(NNIS) system, which is the world's model for the surveillance of
nosocomial infections and for the determination of device-related and
surgical site infection rates. Dr. Jarvis is leading a national and
international effort to reduce central venous catheter (CVC)-associated
bloodstream infections (BSIs). Dr. Jarvis is an author on the
inter-society guideline for the prevention of infections associated
with gastrointestinal endoscopy. Dr. Jarvis currently is Chair of
the FDA's General Hospital and Personal Use Devices Committee.. |
|
|
Dr. Jarvis has been involved in the
evaluation of medical instruments for over 30 years. He has written
guidelines, and conducted outbreak investigations and epidemiologic
studies evaluating such devices. He helped deisgn the CDC NNIS
methodology for determining device-related infections. |
|
|
Dr. Jarvis is a world leader in
nosocomial infection control. He has been President of SHEA, and was on
the SHEA annual meeting planning committee. He was Editor of ICHE
(the SHEA journal). He has been involved in the prevention and control
of nosocomial infections for over 30 years. Dr. Jarvis has written over
350 peer-reviewed publications on this subject, one book, and numerous
guidelines and surveillance reports. He has consulted throughout the
world on infection prevention. He is one of the world's leading experts
in the area. |
|
|
Dr. Jarvis has been a world's
leader in studying the epidemiology and impact of antimicrobial
resistance. He is a co-author of the SHEA Guideline to control
antimicrobial resistance and has conducted numerous interventions
showing how infection control methods (rather than antimicrobial
controls) can reduce the transmission of MRSA, VRE and other
multidrug-resistant pathogens. |
|
|
Dr. Jarvis has conducted studies
of, outbreak investigations of, and written about P. aeruginosa for 30
years. He has authored both chapters and guidelines on this subject. He
has presented at national and international meetings on this subject. |
|
|
Dr. Jarvis has conducted outbreak
investigations of and written widely about this pathogen. He is viewed
as one of the world's leading experts in the epidemiology of this
pathogen in hospital infections. |
|
|
Dr. Jarvis spent 23 years in the
U.S. Public Health Service (PHS), rising to the rank of Captain
(retired). He was at CDC for these 23 years and is viewed as a world's
expert in public health. He has interacted and collaborated with other
PHS agencies, including the FDA and NIH, with the WHO, and with U.S.
state health department personnel. He has collaborated with other PHS
agencies on outbreak investigations, guideline development, and
epidemiologic studies. He has a very solid understanding of how the
public health system works in the United States and throughout the
world. |
|
|
Dr. Jarvis is a world's expert in
staphylococcal infections. He has conducted numerous studies, written
guidelines, and investigated outbreaks involving these pathogens. He
has conducted studies showing how to reduce infections by these
pathogens. He has treated many children with staphylococcal infections.
He was an author on the first description of a vancomycin
intermediate-resistant Staphylococcus
aureus (VISA) strain in the
United States. He wrote the guideline for prevention of transmission of
VISA and VRSA. He is an author of the SHEA Guideline for the control of
MRSA, VRE, VISA and VRSA. He has conducted numerous studies documenting
the efficacy of active surveillance cultures, contact precautions, and
hand hygiene in the control of transmission of VRE in healthcare
settings. He has consulted with medical manufacturers and with
medico-legal experts on prevention and control of staphylococcal
infections. He has been an advocate for the implementation of
evidence-based Active Detection and Isolation (ADI) for the control of
MRSA.
|
|
|
Dr. Jarvis is a world's expert in
surgical infection epidemiology and prevention. He is a co-author on
the
CDC
Guideline for Prevention of Surgical Site Infection (SSI). He was a
member of the team which designed the CDC NNIS system surgical site
surveillance program and surgical site risk index. He has conducted
numerous studies of, and has made presentations throughout the world
on, SSI prevention. Dr. Jarvis has consulted with medical manufacturers
on SSI prevention. He has conducted numerous outbreak investigations
and published on SSI prevention and risk factors. He has
experience investigating increased SSI rates in inpatient and
outpatient settings.
|
|
|
As a pediatric infectious disease
expert, Dr. Jarvis is very familiar with vaccination strategies. He has
conducted numerous studies of vaccine preventable diseases and the
impact of vaccination on infectious diseases in international settings.
He is an author of many chapters in the AAP Red Book, the national and
internationalreference text for vaccination practices. |
|
|
Dr. Jarvis is trained in pediatrics
and pediatric infectious diseases. He has attended in pediatric
infectious diseases at Emory University School of Medicine for over 20
years. He was on the faculty at Emory University School of Medicine
Department of Pediatrics. He has conducted numerous outbreak
investigations and studies in pediatric infectious diseases. He
designed and initiated the Pediatric Prevention Network while he was at
the CDC.
|
Secondary Expertise
acquired immunodeficiency syndrome, acute
wound, antibiotic, antimicrobial medical
device, antiseptic material, artificial
joint, bacitracin, bacterial disease, bacterial
pneumonia, bacteriology, bacterium, biomedical
device, biomedical diagnostic instrumentation, biomedical
instrumentation, biomedicine, blood
transfusion, burn surgery, bypass surgery, cannula,
cardiovascular surgery, catheterization,
chickenpox, clinical immunology, clinical
laboratory, clinical protocol, clinical
research management, clinical trial design, diagnostics,
disease, disinfectant, disinfection,
disposable medical device, endoscope, fungus
disease, gastroenterology, geriatrics, germicide,
governmental registration process, hip
surgery, hospital equipment, hospital
equipment safety, host resistance, humoral
immunology, hygiene, immunology, implantable
device, infection process, infectious
cardiovascular disease, infectious digestive system
disease, infectious disease diagnosis, infectious
disease treatment, infectious gastrointestinal system
disease, infectious lymphatic system disease, infectious
mononucleosis, infectious musculoskeletal disease, infectious
nervous system disease, infectious reproductive system
disease, infectious respiratory system disease, infectious
skin disease, infectious urinary system disease, legionellosis,
medical waste disinfection, microbial
control, minimally invasive surgery, neonatology,
pertussis, plastic medical device, preventive
medicine, skin blister prevention, spine
surgery, staphylococcal enterotoxin, sterilant,
streptococcal infection, streptomycin,
surgery, surgical care, surgical
instrument, surgical product, surgical
staple, therapeutic device, toxic shock
syndrome, tuberculous meningitis, viral
disease, water disinfectant, water
disinfection, wound healing
Basic Expertise
anesthesiology, angioplasty, angioplasty
equipment, anthrax, antibody, antibody
production, antimicrobial additive, antimicrobial
coating, artificial cardiac pacemaker, artificial
eye, artificial heart, artificial kidney, artificial
liver, artificial organ, Band-Aid, bioabsorbable
material, bio-clean room, biocompatible
material, blood sampling, bone healing, botulism,
brucellosis, cannulation, cardioplegia,
catheter tubing, cellular immunology, cold
gaseous sterilant, cold liquid sterilant, cytomegalic
inclusion disease, disposable surgical product, electrocardiograph,
electrocautery instrument, electroencephalograph,
electronic medical device, electrosurgery,
electrosurgical instrumentation, emergency
medicine, eye surgery, fetal wound healing,
gonorrhea, heart-lung machine, hip
replacement, hysterectomy, laser surgery, leptospirosis,
listeriosis, Lyme disease, mechanical
organ, medical filter, medical inhaler, medical
oxygen concentrator, microsurgery, molecular
immunology, nephrology, neurology, neurosurgery,
nocardiosis, oral surgery, orthopaedic
surgery, otolaryngologic surgery, paratyphoid
fever, plastic surgery, prosthesis, prosthetic
material, rectal surgery, serology, skin
substitute, stent, therapeutics, thoracic
surgery, ureteroscopic device, urologic
surgery |